Search
for
Sort by
Research 181–210 of 1000+
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis
- Evaluation of Antiarthritic and Antinociceptive Effects of Cedrol in a Rat Model of Arthritis
- Nanomedicine-based immunotherapy for tissue regeneration
- Therapeutic Potential of Chitosan-Based and Related Nanocomposite Systems in Wound Management: A Review
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- A novel chitosan-peptide system for cartilage tissue engineering with adipose-derived stromal cells
- Endogenous/exogenous stimuli‐responsive smart hydrogels for diabetic wound healing
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis
- Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma
- Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanisms
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Hair Follicle: A Novel Source of Multipotent Stem Cells for Tissue Engineering and Regenerative Medicine
- Dermatological drugs, topical agents, and cosmetics
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Current management strategies for cutaneous T-cell lymphoma
- CUTANEOUS T-CELL LYMPHOMA
- Hypersensitivity Reactions to Anticoagulant Drugs
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate
- Topical use of systemic drugs in dermatology: A comprehensive review
- Interferon in the treatment of cutaneous T-cell lymphoma
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- Regulatory T Cells: the Many Faces of Foxp3